The statements below are read from AAKAAR MEDICAL TECHNO LTD’s filed results, 2 filed quarters and 7 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed Jul 18, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H1 FY26Sep 2025 | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|---|
| Sales | 25.3 | 41.6 | — |
| 25.6 | 31.2 | — | |
| Operating profit | -0.23 | 10.4 | — |
| OPM % | -0.9% | 25.0% | — |
| Other income | 0.30 | 0.63 | — |
| Interest | 1.04 | 0.76 | — |
| Depreciation | 0.05 | 0.08 | — |
| Profit before tax | -1.02 | 10.2 | — |
| Tax % | n/a (loss) | 27.3% | — |
| Net profit | -0.78 | 7.42 | — |
| EPS (₹) | -0.63 | 5.24 | — |
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
